Christian Tang Axelsen, Steen Baerentzen, N. Aggerholm-Pedersen, Hanne Krogh Rose
{"title":"骨恶性巨细胞瘤:最近两例用Denosumab治疗立即见效的病例","authors":"Christian Tang Axelsen, Steen Baerentzen, N. Aggerholm-Pedersen, Hanne Krogh Rose","doi":"10.26502/jcsct.5079168","DOIUrl":null,"url":null,"abstract":"Giant Cell Tumour of Bone (GCTB) is a rare locally aggressive tumor that in 2-4% can contain a malignant component. Due to the rarity there is only sparse evidence on how to treat it in the metastatic setting. On the contrary denosumab has shown promising results on benign GCTB. Here we present two patients with malignant metastatic GCTB treated with Denosumab with partial response evaluated with RECIST 1.1. This indicates that denosumab can be added as a well- tolerated treatment option for malignant metastatic GCTB.","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Malignant Giant Cell Tumour of the Bone: Two Recent Cases with Immediate effect of Treatment with Denosumab\",\"authors\":\"Christian Tang Axelsen, Steen Baerentzen, N. Aggerholm-Pedersen, Hanne Krogh Rose\",\"doi\":\"10.26502/jcsct.5079168\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Giant Cell Tumour of Bone (GCTB) is a rare locally aggressive tumor that in 2-4% can contain a malignant component. Due to the rarity there is only sparse evidence on how to treat it in the metastatic setting. On the contrary denosumab has shown promising results on benign GCTB. Here we present two patients with malignant metastatic GCTB treated with Denosumab with partial response evaluated with RECIST 1.1. This indicates that denosumab can be added as a well- tolerated treatment option for malignant metastatic GCTB.\",\"PeriodicalId\":73634,\"journal\":{\"name\":\"Journal of cancer science and clinical therapeutics\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of cancer science and clinical therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26502/jcsct.5079168\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cancer science and clinical therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26502/jcsct.5079168","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Malignant Giant Cell Tumour of the Bone: Two Recent Cases with Immediate effect of Treatment with Denosumab
Giant Cell Tumour of Bone (GCTB) is a rare locally aggressive tumor that in 2-4% can contain a malignant component. Due to the rarity there is only sparse evidence on how to treat it in the metastatic setting. On the contrary denosumab has shown promising results on benign GCTB. Here we present two patients with malignant metastatic GCTB treated with Denosumab with partial response evaluated with RECIST 1.1. This indicates that denosumab can be added as a well- tolerated treatment option for malignant metastatic GCTB.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
